Park Ha Biological Technology Co., Ltd. (PHH) Stock Overview
Explore Park Ha Biological Technology Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Park Ha Biological Technology Co., Ltd. (PHH)
Key Financials
Key Financials
Market Cap
10M
P/E Ratio
21.08
EPS (TTM)
$-0.72
ROE
0.38%
PHH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Park Ha Biological Technology Co., Ltd. (PHH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.08 and a market capitalization of 10M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.